3647 results for «530»
3647 results
TAVI procedural complications - Part 4: vascular complications, coronary issues and more
20 May 2026 – From EuroPCR 2026
This session addresses a spectrum of procedural complications encountered in TAVI, focusing on vascular issues, coronary challenges, and device-related difficulties. Case presentations include partial prosthesis expansion, emergency thoracic aortic stenting, repeat balloon valvuloplasty, revascularization dilemmas, and complex valve-in-valve procedures. The discussion provides practical perspectives on managing...
Tough scenarios in multivessel disease
20 May 2026 – From EuroPCR 2026
This session addresses challenging scenarios in multivessel coronary artery disease (CAD), particularly when surgical options are limited. Case discussions include IVUS-guided PCI with rotational atherectomy, management of combined severe aortic stenosis and multivessel disease, acute mitral regurgitation with cardiogenic shock, anomalous coronary anatomy, severe kidney disease,...
Advanced mitral TEER strategies in complex clinical scenarios
20 May 2026 – From EuroPCR 2026
This session presents advanced strategies for mitral transcatheter edge-to-edge repair (TEER) in complex clinical settings. Through cases involving surgical ring dehiscence, acute mitral regurgitation, dextrocardia, congenital anomalies, severe annular calcifications, and creative procedural approaches, it explores the expanding role of TEER. The session provides guidance on...
Interventions for hypertension: latest developments
20 May 2026 – From EuroPCR 2026
This session reviews the latest developments in interventional treatments for hypertension, focusing on renal denervation (RDN) technologies and clinical outcomes. It includes comparative procedural data from global registries and studies, novel computational assessments, and applications in specific patient populations such as those with polycystic kidney disease...
New strategies in STEMI treatments
20 May 2026 – From EuroPCR 2026
Investigate new strategies in STEMI treatment through data from international registries and clinical trials. This session examines the comparative efficacy of sirolimus versus paclitaxel-coated balloons, plaque modification in calcified lesions, novel cardioprotective techniques during primary PCI, and the role of AI-assisted ECG interpretation in STEMI pathways.
Bifurcation PCI with complications - Part 1
20 May 2026 – From EuroPCR 2026
This session addresses complications encountered during bifurcation PCI through real-world cases involving stent dislodgement, entrapped guidewires, failed wiring techniques, and fractured devices. It highlights technical rescue maneuvers, the role of intravascular imaging, and long-term challenges encountered in managing complex bifurcation lesions to improve procedural success and...
Optimal timing of aspirin discontinuation: when early is too early?
20 May 2026 – From EuroPCR 2026
This session critically evaluates the optimal timing for aspirin discontinuation after PCI, discussing outcomes of aspirin-free strategies initiated within one month versus three months post-procedure. It considers differential effects of DAPT duration based on ACS presentation and bleeding risk, supported by meta-analyses and real-world data to...
TAVI: new approach
20 May 2026 – From EuroPCR 2026
This session introduces new frontiers in transcatheter aortic valve implantation (TAVI), including artificial intelligence-enabled systems and minimalist, radiation-free approaches guided by echocardiography. It covers complex procedural techniques such as axillary access under TEE guidance, precision snaring, and managing challenging anatomies, emphasizing advancements in safety and efficacy...
Assessment of vasomotor coronary disorders in the cathlab
20 May 2026 – From EuroPCR 2026
This session focuses on the invasive assessment of vasomotor coronary disorders within the catheterization laboratory. It reviews clinical profiles, endothelial function evaluation using acetylcholine and advanced hemodynamic methods, coronary volume analysis, and refined classification of coronary spasm, enhancing diagnostic accuracy in patients with suspected ischemia and...
Management of calcified lesions in challenging scenarios
20 May 2026 – From EuroPCR 2026
This session presents complex cases involving calcified coronary lesions in challenging clinical scenarios including STEMI, bifurcation lesions, tortuosity, and concurrent TAVI procedures. It demonstrates integrative strategies such as rota-lithotripsy and addresses decision-making processes in managing calcification beyond the coronaries to optimize patient outcomes.
Bioresorbable devices in clinical practice
19 May 2026 – From EuroPCR 2026
This session examines the evolving role of bioresorbable devices in coronary intervention, showcasing hybrid PCI strategies, novel applications in myocardial bridging, and innovative solutions for complex coronary lesions, including the use of bioadaptors and dual-device techniques.
Radial and distal radial artery access for PCI
19 May 2026 – From EuroPCR 2026
This session provides an in-depth evaluation of radial and distal radial artery access for PCI, including a 20-year trend analysis of clinical outcomes, feasibility studies on distal radial interventions, and comparative real-world experiences. It also features meta-analyses of randomized trials on access approaches and early findings...
Complex transfemoral TAVI: how to manage the root to success
20 May 2026 – From EuroPCR 2026
Addressing the challenges of complex transfemoral TAVI, this session provides expert guidance on managing difficult vascular access routes to ensure procedural success. Topics include advanced techniques for straightening pathways, managing hostile access, and innovative strategies for contrast-zero TAVI in challenging anatomies.
Primary PCI in challenging anatomy
19 May 2026 – From EuroPCR 2026
Focusing on primary PCI in challenging coronary anatomies, this session covers intracoronary thrombolysis for ectasia, imaging-guided no-stent strategies in vein graft occlusions, and management of coronary aneurysms presenting with acute coronary syndromes, highlighting tailored interventional approaches.
How to face resistent hypertension: when pharmacological treatment is not an option
19 May 2026 – From EuroPCR 2026
Focused on resistant hypertension, this session explores interventional options when pharmacological treatments fall short. It discusses urgent intervention indications, complex cases involving renal artery occlusion, and the role of fractional flow reserve (FFR) in managing pan-vascular disease associated with hypertension.
New techniques and tips in CTO PCI
19 May 2026 – From EuroPCR 2026
This session presents new techniques and practical tips in chronic total occlusion (CTO) percutaneous coronary intervention (PCI). It covers innovative approaches such as the side-flap technique, simplified antegrade strategies for calcified lesions, and retrograde CTO techniques, providing valuable insights into overcoming challenging occlusions.
Unusual NSTEMI lesions and cases
19 May 2026 – From EuroPCR 2026
This session presents a collection of unusual NSTEMI cases characterized by atypical lesion patterns and diagnostic challenges. Topics include surprising unstable angina presentations, complex ostial lesions of the left circumflex artery, and the critical role of OCT imaging in preventing adverse outcomes.
INOCA/ANOCA: technical aspects
20 May 2026 – From EuroPCR 2026
This session covers technical aspects critical to the evaluation and management of ischemia with non-obstructive coronary arteries (INOCA) and angina with non-obstructive coronary arteries (ANOCA). Key topics include the impact of guide catheter shape, injection techniques for thermodilution measurements, advanced perfusion CMR diagnostics, and the physiological...
News from drug-eluting therapies in 2026
19 May 2026 – From EuroPCR 2026
This session presents the latest advancements in drug-eluting therapies for 2026, including predictors of target lesion failure after drug-coated balloon treatment, clinical outcomes related to stenting length, and novel insights into sirolimus transfer evidenced by in vivo OCT imaging.
TAVI complications: impact and improvement
20 May 2026 – From EuroPCR 2026
This session examines critical complications associated with TAVI and strategies to mitigate their impact. Topics include carbon-dioxide flushing to reduce brain injury, management of cardiac tamponade, AI-driven customization of TAVI in complex anatomies, and the influence of vascular complications on post-procedural quality of life.